Hikma Pharmaceuticals plc. revenue breakdown overview

Hikma Pharmaceuticals plc. revenue for the last year amounted to 2.88 B USD, the most of which — 1.23 B USD — came from its highest performing source at the moment, Injectables, the year earlier bringing 1.12 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Hikma Pharmaceuticals plc. 1.77 B USD, and the year before that — 1.41 B USD.